Ascendis to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026
Key Highlights
- ➤Ascendis will report Q3 2026 financial results November 12 before U.S. market open
- ➤Conference call and live webcast scheduled for 8:00 a.m. ET November 12
- ➤Ascendis will provide a business update alongside third-quarter financial results
COPENHAGEN, Denmark, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report third quarter 2026 financial results and provide a business update on Thursday, November 12, 2026, before the open of the U.S. financial markets. Ascendis Pharma also plans to host a conference call and live webcast at 8:00 a.m. Eastern Time (ET) that day to discuss its third quarter 2026 financial results and business update.
Those who would like to participate may access the live webcast here, or register in advance for the teleconference here. The link to the live webcast will also be available on the Investors & News section of the Ascendis Pharma website at https://investors.ascendispharma.com. A replay of the webcast will be available on this section of the Ascendis Pharma website shortly after the conclusion of the event for 30 days.
Get started
Create a free account to read the full story.